Market Insights Health Medical Technology Medical Devices

Cardiology Devices - Jordan

Jordan

The projected revenue in the Cardiology Devices market market in Jordan is expected to reach US$55.13m in 2024.
It is anticipated that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of 6.44%, leading to a market volume of US$75.32m by 2029.
When compared to other countries globally, the United States is projected to generate the highest revenue, amounting to US$25,770.00m in 2024.
Despite the challenges posed by limited resources, Jordan has seen a steady growth in the adoption of advanced cardiology devices in recent years.

Key regions: United Kingdom, United States, France, Spain, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Cardiology Devices market in Jordan is experiencing steady growth, driven by increasing customer preferences for advanced medical technologies and the rising prevalence of cardiovascular diseases in the country. Customer preferences in the Cardiology Devices market in Jordan are shifting towards technologically advanced and minimally invasive devices. Patients are seeking innovative solutions that offer better outcomes, shorter recovery times, and reduced risks. This trend is in line with global market preferences, as advancements in medical technology continue to revolutionize the field of cardiology. Trends in the market include the increasing adoption of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices. These devices are used to treat patients with heart failure and arrhythmias, and their demand is rising due to the growing prevalence of these conditions in Jordan. Additionally, there is a growing demand for remote monitoring systems, which allow healthcare providers to remotely monitor patients' cardiac health and intervene when necessary. This trend is driven by the need for continuous care and the convenience it provides to both patients and healthcare professionals. Local special circumstances in Jordan have also contributed to the development of the Cardiology Devices market. The country has a high prevalence of cardiovascular diseases, which can be attributed to factors such as sedentary lifestyles, unhealthy diets, and an aging population. As a result, there is a greater need for advanced cardiology devices to diagnose and treat these conditions. Additionally, the government of Jordan has been investing in healthcare infrastructure and promoting medical tourism, which has further fueled the demand for cardiology devices. Underlying macroeconomic factors, such as the growing economy and increasing healthcare expenditure, have also played a role in the development of the Cardiology Devices market in Jordan. The country's healthcare sector has been expanding, with a focus on improving access to quality healthcare services. This has led to increased investment in medical technologies, including cardiology devices. Furthermore, the government has implemented policies to encourage local manufacturing of medical devices, which has further boosted the market. In conclusion, the Cardiology Devices market in Jordan is experiencing growth due to customer preferences for advanced technologies, the rising prevalence of cardiovascular diseases, local special circumstances, and underlying macroeconomic factors. As the market continues to evolve, it is expected that there will be further advancements in cardiology devices and an increased focus on preventive care and remote monitoring solutions.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.